San Diego-based mostly Viking Therapeutics marked by itself as a serious competitor within the weight loss drug market place in February soon after revealing promising details from a mid-stage trial of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when provided for a weekly injection As well as in Marc